Carcinoma, Hepatocellular: all 3,249 studies
Page 5 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.
- Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular CarcinomaRecruitingNCT06864221
- Exploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort StudyRecruitingNCT06861114
- HAIC Combined With Sintilimab Plus Bevacizumab Biosimilar for Advanced Hepatocellular Carcinoma (TASK-03)RecruitingNCT06860490Phase 2
- 68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)RecruitingNCT06852820Phase 2
- A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX13 with YERVOY As a First-Line Treatment for Patients with Unresectable Hepatocellular CarcinomaNot yet recruitingNCT06841185Phase 3
- Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCCRecruitingNCT06841172Phase 3
- Comparative Study of Carvedilol Monotherapy Versus Combination Therapy With Endoscopic Variceal Ligation (EVL) for Primary Prophylaxis of Variceal Bleeding in Patients With Hepatocellular Carcinoma With High-Risk Esophageal VaricesNot yet recruitingNCT06836778Not applicable
- Sialic Acid in Hepatocellular CarcinomaNot yet recruitingNCT06836518
- Time-restricted Eating and Healthy Eating in Patients With Metabolic Liver Disease or CancerRecruitingNCT06824974Not applicable
- A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAICNot yet recruitingNCT06823050
- QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular CarcinomaNot yet recruitingNCT06822985Phase 1
- Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early DiagnosisRecruitingNCT06822413
- Amplitude-modulated Radiofrequency Electromagnetic Field Treatment for Advanced Hepatocellular Carcinoma (Immune-RF)RecruitingNCT06821958Not applicable
- Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCCRecruitingNCT06819566Phase 2
- Prognostic Factors for HCC and Liver Transplantation in Patients with MASLD/MASHRecruitingNCT06813508
- HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of RecurrenceRecruitingNCT06812039Phase 2
- Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE TrialRecruitingNCT06811116Phase 1/2
- Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular CarcinomaRecruitingNCT06806579
- Sarcopenia and Systemic Therapy in HCCRecruitingNCT06805552
- Fusing Ultrasound and Magnetic Resonance Imaging to Intelligently Plan Highly Conformal Ablation Thermal Field for Hepatocellular CarcinomaNot yet recruitingNCT06798194
- Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)RecruitingNCT06796803Phase 2/3
- Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and DurvalumabRecruitingNCT06796114Not applicable
- First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid TumoursRecruitingNCT06795022Phase 1/2
- Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical StudyRecruitingNCT06794073Not applicable
- Ga-68 Dolacga PET Scan in HCC Under RFANot yet recruitingNCT06792097
- Ligufalimab and Cadonilimab in Advanced Liver CancersRecruitingNCT06789848Phase 2
- The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)RecruitingNCT06789757Phase 2
- Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular CarcinomaRecruitingNCT06788353
- Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.Not yet recruitingNCT06786429Phase 4
- A Clinical Trial Assessing the Safety and Efficacy of Biodegradable Magnesium Embolic Microspheres for Primary Hepatocellular CarcinomaNot yet recruitingNCT06779461Phase 3
- mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With CirrhosisRecruitingNCT06778317
- Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular CarcinomaRecruitingNCT06777628
- Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation?RecruitingNCT06777017
- Use of Machine-learning Algorithms, Biomarkers and Measures of Quality of Life to Personalize Medical Management of Liver and Heart Transplant RecipientsNot yet recruitingNCT06774768
- Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational StudyRecruitingNCT06774690
- Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 CriteriaRecruitingNCT06773845Phase 2
- Liver and Spleen Stiffness to Predict the Presence of Esaphageal Varices in Cirrhotic with Advanced HCCEnrolling by invitationNCT06773260
- Part of the Modern Art StudyNot yet recruitingNCT06768242Not applicable
- A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver CancerRecruitingNCT06764316Phase 1
- Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After SurgeryRecruitingNCT06762782Phase 2
- Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory ApprovalAvailableNCT06751524
- The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular CarcinomaNot yet recruitingNCT06750159
- Effect of Prehabilitation During the Conversion Therapy on Postoperative Outcomes in Unresectable Hepatocellular CarcinomaNot yet recruitingNCT06749678Not applicable
- The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor TherapyRecruitingNCT06746194
- A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard TherapyRecruitingNCT06742892Phase 2
- PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCCRecruitingNCT06742424Phase 2
- Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular CarcinomaRecruitingNCT06741020Phase 1/2
- TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular CarcinomaRecruitingNCT06740370Not applicable
- SBRT Combined with Camrelizumab and Apatinib for Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma.Not yet recruitingNCT06739317Phase 2/3
- Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NENRecruitingNCT06735560Not applicable
- Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCCRecruitingNCT06726161Phase 1/2
- Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before TransplantRecruitingNCT06725121Phase 1/2
- HOPE Against Cancer Recurrence in HCCRecruitingNCT06717919Phase 4
- The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic ProfilingRecruitingNCT06717295
- Study on the Efficacy and Safety of Transarterial Chemoembolization Combined with Targeted Immunotherapy in Patients with Unresectable Hepatocellular CarcinomaNot yet recruitingNCT06715072
- Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in ChinaEnrolling by invitationNCT06712017
- Spanish Registry of Digestive Tumours RETUDRecruitingNCT06711211
- Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular CarcinomaNot yet recruitingNCT06708650Not applicable
- Y-90 SIRT for Unresectable HCC Larger Than 7cmRecruitingNCT06707233Phase 2
- The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/CT and Enhanced MRI in Hepatic MalignanciesNot yet recruitingNCT06700564
- Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)RecruitingNCT06698250Phase 2
- A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular CarcinomaRecruitingNCT06695026Phase 1/2
- Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular CarcinomaRecruitingNCT06694636Not applicable
- Needle-based Percutaneous Ablation of Liver Tumors.RecruitingNCT06689670Not applicable
- Mts105 for Advanced Hepatocellular CarcinomaRecruitingNCT06689540Phase 1
- A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid TumorsRecruitingNCT06687941Phase 1
- Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot StudyNot yet recruitingNCT06685354Phase 2
- Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial HepatectomyRecruitingNCT06681818Not applicable
- A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic TherapyNot yet recruitingNCT06680258Phase 3
- TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.RecruitingNCT06669377
- Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTTRecruitingNCT06664996Phase 2
- Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver CancerRecruitingNCT06658782
- Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence SurveillanceRecruitingNCT06653062
- Clinical Study of SN301A Injection in the Treatment of Hepatocellular CarcinomaRecruitingNCT06652243Early Phase 1
- A Multicenter Prospective Observational Study of Computer-aided Risk Perception and Prognosis Prediction in the Whole Process of Laparoscopic Hepatobiliary and Pancreatic SurgeryEnrolling by invitationNCT06647264
- Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular CarcinomaNot yet recruitingNCT06645314Early Phase 1
- Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of RecurrenceRecruitingNCT06644937Phase 2/3
- Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)Not yet recruitingNCT06643533
- HAIC Compared With TACE in Huge Hepatocellular CarcinomaRecruitingNCT06641713
- CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular CarcinomaNot yet recruitingNCT06641453Phase 1/2
- Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCCNot yet recruitingNCT06639971
- A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric CancerRecruitingNCT06636435Phase 1
- Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular CarcinomaRecruitingNCT06632717Phase 2
- HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLCRecruitingNCT06632093
- Ten-Year Outcomes of Operable Solitary Hepatocellular Carcinoma Patients: Impact of Tumor Size Over 6.5 Cm and Microvascular InvasionRecruitingNCT06628661
- Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With CirrhosisEnrolling by invitationNCT06624189
- Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular CarcinomaRecruitingNCT06624098Not applicable
- Correlation Study of Lipid Metabolites as Markers of Hepatocellular CarcinomaRecruitingNCT06623474
- TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTTRecruitingNCT06622031Not applicable
- Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection SurgeryRecruitingNCT06621472Not applicable
- A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-RelatedRecruitingNCT06617000Phase 1
- Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCCRecruitingNCT06609876Not applicable
- dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular CarcinomaRecruitingNCT06609863Not applicable
- The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular CarcinomaRecruitingNCT06609850Not applicable
- Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target TherapiesRecruitingNCT06607120
- mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan CriteriaRecruitingNCT06607107Phase 2
- Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and BevacizumabRecruitingNCT06605664Phase 2
- Measuring the Density of Iodine in Lipiodol Depositions: Detecting an Invisible Residual Tumor After Conventional Transarterial Chemoembolization for Hepatocellular CarcinomaNot yet recruitingNCT06602986Not applicable
- Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)RecruitingNCT06602011
- A Study to Evaluate ALN-BCAT in Patients With Hepatocellular CarcinomaRecruitingNCT06600321Phase 1